Minority / Underserved
While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific population groups. Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Minority and Underserved Repurposing Community to support Diversity, Equity & Inclusion efforts that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of minority and underserved patients as well as to support minority and underserved researchers.
We support Diversity, Equity & Inclusion efforts by finding and funding clinical repurposing projects:
- Led by Minority and Underserved Researchers in any disease area
- To positively impact Health Disparities within communities of color
- To impact patients living in low and low-middle income countries (LMICs, as defined by the World Bank)
As we develop and grow this Community, Cures Within Reach thanks our early funding partners:
for its support of our first project in Health Disparities: “Can Vitamin D reduce the burden of COVID-19?” focusing on Black and Hispanic Chicagoans,
for its support of Minority and Underserved communities and researchers, including:
- Treating Tuberculosis with a Lipid Lowering Drug in Nigeria
- Testing the Safety of a Repurposed Drug to Treat Snakebite in Kenya
- Repurposing Fecal Microbiota Transplantation for the Treatment of Pediatric Malnutrition in South Africa (completed)
- Infectious disease in Kenya: pending
- Rare Pediatrics in Vietnam: pending
Current Minority / Underserved Research(er) Projects
Completed Minority / Underserved Research(er) Projects
(in the past 3 years)
Cure Accelerator Live! for Chicago 2020
Four finalists from Chicago-based institutions competing for up to $50,000 to fund their repurposing clinical trials, including a minority-led project. Watch Dr. Lindsey pitch his project.
CureAccelerator Live! for Rare Diseases 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients – including a minority led project. Read more about Dr. Phillips’ project and watch him pitch it.
CureAccelerator Live! for the Developing World 2019
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.